Persistence on Disease Modifying Anti-Rheumatic Drugs Among Taiwan Established Rheumatoid Arthritis Patients

被引：0
|
作者：
Liu, Yi-Han [1 ]
Lin, Tzu-Chieh [1 ,2 ]
Yang, Yea-Huei Kao [1 ,2 ]
Chang, Hui-Jen [3 ]
机构：
[1] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ Hosp, Dept Pharm Serv, Tainan 70428, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
134
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [31] Effect of glucocorticoids combined with disease modifying anti-rheumatic drugs on the improvement of symptoms in patients with rheumatoid arthritis
    Si, Lulu
    Jin, Yunyan
    Zhao, Dongni
    Yu, Lixia
    Cao, Huankun
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (04) : 976 - 980
  • [32] ADVERSE DRUG REACTIONS ASSOCIATED WITH THE USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Machado, J.
    Ruiz, A.
    Machado-Duque, M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A153 - A153
  • [33] IMPROVEMENT OF NUTRITIONAL CONDITIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS STARTING FIRST DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Kobayashi, D.
    Ito, S.
    Hasegawa, E.
    Narita, I.
    Nakazono, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 927 - 927
  • [34] Predictors at Diagnosis for Start of Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis
    Hameed, M.
    Exarchou, S.
    Eberhard, A.
    Sharma, A.
    Bergstrom, U.
    Einarsson, J.
    Turesson, C.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 67 - 68
  • [35] Preferences of patients with rheumatoid arthritis regarding disease modifying anti-rheumatic drugs: a discrete choice experiment
    van Heuckelum, M.
    Mathijssen, E.
    Vervloet, M.
    Boonen, A.
    Hebing, R.
    Pasma, A.
    Vonkeman, H.
    Wenink, M.
    van den Bemt, B.
    van Dijk, L.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 299 - 300
  • [36] Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs
    Pavelka, Karel
    Kavanaugh, Arthur F.
    Rubbert-Roth, Andrea
    Ferraccioli, Gianfranco
    [J]. RHEUMATOLOGY, 2012, 51 : V12 - V21
  • [37] Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis
    Navarro-Millan, Iris
    Goyal, Parag
    Safford, Monika M.
    [J]. RHEUMATOLOGY, 2019, 58 (06) : 933 - 934
  • [38] Time To Institution Of Disease Modifying Anti-Rheumatic Drugs In Australian Patients With Early Rheumatoid Arthritis.
    Van Doornum, Sharon
    Tropea, Joanne
    Tacey, Mark
    Liew, Danny
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S565 - S565
  • [39] Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
    Su, Yu-Jih
    Chen, Hui-Ming
    Chan, Tien-Ming
    Cheng, Tien-Tsai
    Yu, Shan-Fu
    Chen, Jia-Feng
    Lin, Chun-Yu
    Hsu, Chung-Yuan
    [J]. RMD OPEN, 2023, 9 (03):
  • [40] Predictors at Diagnosis for Start of Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis
    Hameed, Mohaned
    Exarchou, Sofia
    Eberhard, Anna
    Sharma, Ankita
    Bergstrom, Ulf
    Einarsson, Jon
    Turesson, Carl
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2831 - 2833
12345